Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 9
2013 8
2014 10
2015 8
2016 7
2017 10
2018 11
2019 11
2020 9
2021 6
2022 11
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Villar S, Chevret S, Poire X, Joris M, Chevallier P, Bourhis JH, Forcade E, Chantepie S, Beauvais D, Raus N, Bay JO, Loschi M, Devillier R, Duléry R, Ceballos P, Rubio MT, Servais S, Nguyen S, Robin M. Villar S, et al. Among authors: devillier r. Bone Marrow Transplant. 2024 Mar 21. doi: 10.1038/s41409-024-02268-5. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38514813
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.
Fürst S, Bernit E, Legrand F, Granata A, Harbi S, Devillier R, Maisano V, Bouchacourt B, Pagliardini T, Mokart D, Lemarié C, Calmels B, Picard C, Basire A, Andersson BS, Blaise D. Fürst S, et al. Among authors: devillier r. Bone Marrow Transplant. 2024 Mar 14. doi: 10.1038/s41409-024-02257-8. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38486114
IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.
Caillet A, Simonet-Boissard M, Forcade E, Robin M, Rubio MT, Couturier MA, Srour M, Maillard N, Devillier R, Huynh A, Bourhis JH, Simand C, Chantepie S, Boisson C, Kroemer M, Deconinck E, Berceanu A. Caillet A, et al. Among authors: devillier r. Hemasphere. 2024 Mar 10;8(3):e44. doi: 10.1002/hem3.44. eCollection 2024 Mar. Hemasphere. 2024. PMID: 38469458 Free PMC article. No abstract available.
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
Lacan C, Lambert J, Forcade E, Robin M, Chevallier P, Loron S, Bulabois CÉ, Orvain C, Ceballos P, Daguindau E, Charbonnier A, Chalandon Y, Bernard M, Simand C, Rubio MT, Turlure P, Maertens J, Huynh A, Loschi M, Bay JO, Guillerm G, Alani M, Castilla-Llorente C, Poiré X, Chantepie S, Maillard N, Beguin Y, Marçais A, Cornillon J, Malfuson JV, Maury S, Meuleman N, Villate A, Bekadja MA, Walter-Petrich A, Jacque N, Srour M, Devillier R, Nguyen S. Lacan C, et al. Among authors: devillier r. J Hematol Oncol. 2024 Jan 7;17(1):2. doi: 10.1186/s13045-023-01515-4. J Hematol Oncol. 2024. PMID: 38185663 Free PMC article.
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Harbi S, Brac de la Perriere L, Bouchacourt B, Garciaz S, Pagliardini T, Calmels B, Cecile M, Lefloch AC, Hicheri Y, Hospital MA, Fürst S, Lemarie C, Braticevic C, Legrand F, Bekrieva E, Weiller PJ, Chabannon C, Vey N, Blaise D, Devillier R. Harbi S, et al. Among authors: devillier r. Bone Marrow Transplant. 2024 Jan;59(1):101-106. doi: 10.1038/s41409-023-02134-w. Epub 2023 Nov 3. Bone Marrow Transplant. 2024. PMID: 37923831
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC.
Rey G, Daguenet E, Bonjean P, Devillier R, Fegueux N, Forcade E, Srour M, Chevallier P, Robin M, Suarez F, Micol JB, Labussière-Wallet H, Bilger K, Daguindau E, Bay JO, Fayard A, Bulabois CE, Nguyen-Quoc S, Genthon A, Orvain C, Turlure P, Loschi M, Poiré X, Guillerm G, Beguin Y, Maillard N, Mear JB, Chalayer E, Cornillon J, Tavernier E. Rey G, et al. Among authors: devillier r. Bone Marrow Transplant. 2023 Dec;58(12):1331-1338. doi: 10.1038/s41409-023-02082-5. Epub 2023 Aug 31. Bone Marrow Transplant. 2023. PMID: 37653054 Free article.
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.
Dachy F, Furst S, Calmels B, Pagliardini T, Harbi S, Bouchacourt B, Calleja A, Lemarie C, Collignon A, Morel G, Legrand F, Bekrieva E, Granata A, Weiller PJ, Chabannon C, Schiano JM, Vey N, Blaise D, Devillier R. Dachy F, et al. Among authors: devillier r. Bone Marrow Transplant. 2023 Nov;58(11):1179-1181. doi: 10.1038/s41409-023-02033-0. Epub 2023 Aug 9. Bone Marrow Transplant. 2023. PMID: 37558780 No abstract available.
Post-transplantation cyclophosphamide combined with tacrolimus and low-dose post-engraftment anti-thymoglobulin as GVHD prophylaxis for patients undergoing peripheral blood stem cell transplantation from haploidentical family donor: A single center analysis.
Gao WH, Zhu JY, Wang LN, Wan M, Wang L, Devillier R, Jiang JL, Blaise D, Hu J. Gao WH, et al. Among authors: devillier r. Front Med (Lausanne). 2023 Mar 31;10:1140217. doi: 10.3389/fmed.2023.1140217. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37064033 Free PMC article.
Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT.
Devillier R, Eikema DJ, Dufour C, Aljurf M, Wu D, Maschan A, Kulagin A, Halkes CJM, Collin M, Snowden J, Renard C, Ganser A, Sykora KW, Gibson BE, Maertens J, Itäla-Remes M, Corti P, Cornelissen J, Bornhäuser M, Araujo MC, Ozdogu H, Risitano A, Socie G, De Latour RP. Devillier R, et al. Haematologica. 2023 Sep 1;108(9):2305-2315. doi: 10.3324/haematol.2022.281876. Haematologica. 2023. PMID: 36951165 Free PMC article.
86 results